SNSE – sensei biotherapeutics, inc. (US:NASDAQ)

News

Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Egle Therapeutics Appoints John Celebi as Chief Executive Officer
Sensei Biotherapeutics (NASDAQ:SNSE) was upgraded by analysts at Wall St
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com